Fulgent Pharma LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2011-06-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.fulgentpharma.com
Study of FID-022 in Participants with Advanced Solid Tumors
- First Posted Date
- 2024-11-19
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Fulgent Pharma LLC.
- Target Recruit Count
- 24
- Registration Number
- NCT06694480
FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Fulgent Pharma LLC.
- Target Recruit Count
- 46
- Registration Number
- NCT06332092
- Locations
- 🇺🇸
Highlands Oncology - North Hills, Fayetteville, Arkansas, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸Moffitt Cancer Center Magnolia Campus, Tampa, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath